| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.04 |